Atrial Fibrillation on Patients with Vascular Dementia: A Fundamental Target for Correct Management

Giovanna Viticchi1, Lorenzo Falsetti2, Marco Burattini1

  • 1Neurological Clinic, Marche Polytechnic University, 60020 Ancona, Italy.

Brain Sciences
|July 8, 2020
PubMed

Insights

Patients with atrial fibrillation and vascular dementia were undertreated with anticoagulants, increasing their stroke risk. Adherence to guidelines is crucial for managing this high-risk group.

Area of Science:

  • Cardiology
  • Neurology
  • Geriatrics

Background:

  • Atrial fibrillation (AF) is a known risk factor for cerebrovascular diseases, including vascular dementia (VAD).
  • Effective anticoagulant therapy is vital for preventing adverse events in AF patients.
  • Assessing guideline adherence in VAD patients with AF is critical for stroke prevention.

Purpose of the Study:

  • To evaluate anticoagulant therapy guideline adherence in patients with both dementia and AF.
  • To assess the impact of adherence on the risk of stroke/TIA or major bleeding (MB).

Main Methods:

  • A cohort study of 1705 hospitalized patients with pre-existent AF, including 193 with VAD.
  • Calculation of CHA2DS2-VASc, CHADS2, and HAS-BLED scores for risk assessment.
  • Collection of data on anticoagulant therapy, therapeutic failure (TF), stroke/TIA, and MB.

Main Results:

  • 99.5% of VAD patients had an indication for anticoagulation, but only 69.9% received appropriate treatment.
  • VAD patients experienced significantly higher in-hospital stroke/TIA rates (24.3%) compared to non-demented patients (0.8%).
  • Major bleeding (MB) rates were comparable between VAD (4.66%) and non-demented patients (8.9%), with similar therapeutic failure rates.

Conclusions:

  • Vascular dementia patients with atrial fibrillation are frequently undertreated with anticoagulants.
  • This undertreatment is associated with a higher risk of stroke/TIA compared to non-demented AF patients.
  • Improved adherence to anticoagulant therapy guidelines is essential for VAD patients with AF.
Abstract

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
284
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
334
Dysrhythmias VII: Nursing Management of Dysrhythmias01:25

Dysrhythmias VII: Nursing Management of Dysrhythmias

Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
246
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
255
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
191
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
2.2K